Blue reliever inhalers act quickly to treat symptoms and attacks, and people need to carry them for if their asthma flares up.However, a new warning from the regulator, the UK's Medicines and ...

Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic ...